← Back
Icu Medical
ICUI · listed on Nasdaq · worth $3.99 billion
$165.96
−1.66% today
No insider bought Icu Medical stock in the last year. They sold it 16 times, $6.55 million in all.
Red dot = an insider soldA number = that many on nearby days · click a mark to see who, or read the filing
The shares anyone can buy and sell, leaving out those held by insiders and big long-term owners.
24.6M shares
98% of all shares
Shares borrowed and sold by investors who expect the price to drop.
Company insiders
In the last year, six insiders sold Icu Medical stock and none bought. Eight of the 16 sales are marked on the filing as planned in advance; most by company executives. The biggest seller was Daniel Woolson, VP, GM-Infusion Capital.
Planned sales
Form 144 notices filed for Icu Medical in recent months, beside the Form 4 sales reported after each. A notice says a person intends to sell; it is not a sale.
Executive Virginia Ruth Sanzone filed to sell 4,856 shares on 3 Sep; sold 4,856 by 3 Sep10b5-1 plan adopted 4 Jun 2026 · Notice on SEC.gov
CFO Brian Michael Bonnell filed to sell 6,381 shares on 1 Sep; sold 9,307 by 31 Aug10b5-1 plan adopted 1 Jun 2026 · Notice on SEC.gov
CFO Brian Michael Bonnell filed to sell 9,307 shares on 31 Aug; no sale reported yet10b5-1 plan adopted 1 Jun 2026 · Notice on SEC.gov
Big investors
People and funds that reported owning 5% or more of Icu Medical, newest first.
All reports
Every insider trade and SEC report we hold for Icu Medical.
Newest first
ReportedTradeInsiderOf their holdingShares @ priceValue
Sep 3SoldVirginia Ruth SanzoneSep 3 · VP, General Counsel · A trade scheduled ahead of time under a written plan, so its timing was set before the day it happened.692 @ $171.52$118.7K
Sep 3SoldVirginia Ruth SanzoneSep 3 · VP, General Counsel · A trade scheduled ahead of time under a written plan, so its timing was set before the day it happened.724 @ $169.53$122.7K
Sep 3SoldVirginia Ruth SanzoneSep 3 · VP, General Counsel · A trade scheduled ahead of time under a written plan, so its timing was set before the day it happened.1,238 @ $168.44$208.5K
Sep 3SoldVirginia Ruth SanzoneSep 3 · VP, General Counsel · A trade scheduled ahead of time under a written plan, so its timing was set before the day it happened.2,202 @ $167.67$369.2K
Aug 31SoldBrian Michael BonnellAug 31 · Chief Financial Officer · A trade scheduled ahead of time under a written plan, so its timing was set before the day it happened.1,113 @ $173.91$193.6K
18 more with Pro →Analysts, earnings and news
Analysts' price target
$174.17 average
6 analysts
Analysts' opinions, which tend to run optimistic. Not our forecast or advice.
Profit vs what was expected
4 of 4 quarters above
Q1 '26$1.97 a share+$0.22
Q4 '25$1.91 a share+$0.22
Q3 '25$2.03 a share+$0.60
Q2 '25$2.10 a share+$0.60